GLA
GLA, licence 80081837: active licence in Health Canada data. The French and European references below do not constitute authorisation for sale in France or an assessment of safety or efficacy.
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
Natural health product licensed in Canada
- Other names
- AOR GLA, Borage-500, GLA-120, GLA-120 Vegan
- Licence holder
- Advanced Orthomolecular Research Inc.
- NPN or DIN-HM
- 80081837
- Status
- Active licence
- Licence date
- 13 December 2017
- Revision date
- 4 December 2022
- Form
- Capsule, molle
- Route of administration
- Orale
- Application type
- Officinale
If this product were sold in France
- Conditions légales
Borago officinalis L.: Les préparations de cette plante sont autorisées s'il peut être démontré qu'elles ne dépassent pas 1 ppb d'alcaloïdes pyrrolizidiniques.
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Borago officinalis Source : Borago officinalis - Graine Potency : 120.0 mg gamma-Linolenic acid | 522.0 mg | Not calculated |
Non-medicinal ingredients
Tocophérols, Sirop de riz brun, NA, Eau purifiée, Carraghénine, Isolat de protéines de pois, Glycérine, Sodium complexe de cuivre chlorophylline, Lécithine
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | minimum: 19.0 Année(s) | 2.0 Capsule | minimum: 1.0 Tous les jours ; maximum: 3.0 Tous les jours |
Uses authorised in Canada
Source of essential fatty acids for the maintenance of good health. Source of omega-6 fatty acids for the maintenance of good health. Source of linoleic acid (LA) for the maintenance of good health. Source of gamma-linoleic acid.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Source
Official Health Canada record, licence 80081837
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).
List recorded in 2022. Photograph the packaging to check whether it has changed.
Has the product changed? Photograph the packaging.